Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 213, Issue 10, Pages 1562-1572
Publisher
Oxford University Press (OUP)
Online
2015-12-25
DOI
10.1093/infdis/jiv762
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994–2010
- (2015) Piraya Bhoomiboonchoo et al. BMC PUBLIC HEALTH
- Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial
- (2015) Sarah L. George et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
- (2014) Jorge E Osorio et al. LANCET INFECTIOUS DISEASES
- Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: A meta-analysis of randomized trials
- (2014) Vivaldo G. da Costa et al. VACCINE
- Vaccine-Mediated Immunity Against Dengue and the Potential for Long-Term Protection Against Disease
- (2014) Mark K. Slifka Frontiers in Immunology
- Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection
- (2013) Maria G. Guzman et al. ARCHIVES OF VIROLOGY
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Identifying protective dengue vaccines: Guide to mastering an empirical process
- (2013) Scott B. Halstead VACCINE
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Dengue
- (2012) Cameron P. Simmons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Features of Dengue in a Large Vietnamese Cohort: Intrinsically Lower Platelet Counts and Greater Risk for Bleeding in Adults than Children
- (2012) Trung Dinh The et al. PLoS Neglected Tropical Diseases
- Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
- (2011) Jorge E. Osorio et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Priming Effect of Dengue and Yellow Fever Vaccination on the Immunogenicity, Infectivity, and Safety of a Tetravalent Dengue Vaccine in Humans
- (2011) Ming Qiao et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Critical issues in dengue vaccine development
- (2011) Stephen J. Thomas et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Dengue: a continuing global threat
- (2010) Maria G. Guzman et al. NATURE REVIEWS MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started